Introduction :

Dolphin Pharmaceutical is a leading Ibandronic Acid supplier from India, based in Surat, Gujarat, specializing in the global supply of high-quality specialty medicines. We serve pharmaceutical importers, distributors, hospitals, and healthcare organizations worldwide with quality-assured Ibandronic Acid.

Ibandronic Acid is primarily used for the treatment of osteoporosis, under the supervision of qualified healthcare professionals. Dolphin Pharmaceutical is committed to providing authentic medicines, competitive pricing, complete support, global healthcare requirements.

Bonimet 6 mg Injection

Bonimet 6 mg Injection (Ibandronic Acid) is marketed by Intas Pharmaceuticals Ltd., with India listed as its country of origin. It belongs to the bisphosphonate class of medicines and acts as a bone-resorption inhibitor by suppressing osteoclast activity, thereby reducing bone breakdown. It is used primarily in the management of postmenopausal osteoporosis and, depending on the approved indication, to treat cancer-related hypercalcaemia or help prevent skeletal complications in patients with cancer that has spread to the bones. It is administered by a healthcare professional under medical supervision

Product Introduction

Ibandronic Acid 6 mg Injection is a prescription medicine used to manage certain conditions associated with abnormal calcium levels and bone loss. It belongs to a group of medicines known as bisphosphonates, which help reduce excessive bone breakdown. Depending on the active ingredient and the approved indication, medicines in this class may be used to treat hypercalcaemia associated with malignancy and selected bone disorders.

This medicine is administered by a qualified healthcare professional. The dosage, frequency, and duration of treatment depend on the patient's diagnosis, kidney function, calcium levels, and overall medical condition. Adequate hydration and appropriate laboratory monitoring may be necessary before and after administration.

Ibandronic Acid 6 mg Injection should be used only under medical supervision. The exact active ingredient and approved uses should be confirmed from the product label, as the indications and dosing schedules of bisphosphonate medicines vary.

Uses of Ibandronic Acid 6 mg Injection

• Hypercalcaemia: Used to manage abnormally elevated calcium levels in the blood, including certain cases associated with cancer.

• Bone disorders: Depending on the confirmed active ingredient and product approval, bisphosphonates may be used for selected conditions involving reduced bone density or increased bone resorption.

The indications listed for Ibandronic Acid should be verified against its official prescribing information. Not all bisphosphonates are approved for every condition described above.

Benefits of Ibandronic Acid 6 mg Injection

A. Management of Hypercalcaemia

Hypercalcaemia is a condition in which the calcium concentration in the blood becomes higher than normal. It can occur in patients with certain cancers when calcium is released from bones or when the body's calcium regulation is disrupted.

Bisphosphonates reduce the activity of osteoclasts, the cells responsible for breaking down bone tissue. This can decrease the release of calcium from bones into the bloodstream and help lower elevated blood calcium levels.

Treatment may require hydration, blood tests, and other supportive measures according to the cause and severity of the condition. Patients should follow their healthcare professional's advice regarding calcium and vitamin D supplements.

B. Management of Bone Loss

Osteoporosis is a condition in which bones become less dense and more fragile, increasing the risk of fractures. It can occur after menopause, with advancing age, or following prolonged use of certain medicines, including corticosteroids.

Bisphosphonates help slow bone resorption by reducing osteoclast activity. This may help preserve bone mineral density and lower the risk of fractures when the medicine is appropriate for the patient's condition.

Bone health can also be supported through suitable weight-bearing exercise, adequate dietary calcium and vitamin D, and lifestyle changes recommended by a healthcare professional.

Possible Side Effects

Some side effects may occur during treatment. These can vary according to the active ingredient, dose, and individual response.

Commonly reported effects of some bisphosphonate medicines include:

• Headache

• Bone, muscle, or joint pain

• Indigestion or heartburn

• Diarrhoea

• Pain, redness, or swelling at the injection site

Many mild effects resolve over time, but persistent or worsening symptoms should be discussed with a doctor.

Serious precautions

Bisphosphonates can sometimes cause kidney complications, low blood calcium levels, and, rarely, osteonecrosis of the jaw. Patients should seek prompt medical advice if they experience symptoms such as muscle spasms, tingling around the mouth, unusual weakness, or persistent jaw pain.

Kidney function and blood mineral levels may need to be checked before and during treatment. Patients should inform their doctor about existing kidney disease, low calcium levels, pregnancy or breastfeeding, dental problems, and all medicines or supplements they use.

Mechanism of Action Ibandronic Acid

Ibandronic Acid is described as a bisphosphonate medicine. Bisphosphonates act primarily by inhibiting osteoclast-mediated bone resorption.

Osteoclasts are specialised cells that break down old bone tissue as part of normal bone remodelling. When their activity becomes excessive, bone loss can increase and calcium may be released into the bloodstream.

By suppressing osteoclast activity, an appropriate bisphosphonate can reduce bone breakdown, help preserve bone mineral density, and, in certain cancer-related conditions, lower elevated blood calcium levels.

The precise mechanism, approved indications, and dosing regimen for Ibandronic Acid must be confirmed using its active ingredient and official product information.

Conclusion

Ibandronic Acid Injection is presented as a bisphosphonate medicine intended for the management of selected conditions involving elevated blood calcium or abnormal bone resorption. Its principal mechanism is to reduce osteoclast activity and slow the breakdown of bone tissue.

Because the indications and dosing schedules of bisphosphonates differ, the active ingredient and official prescribing information should be verified before describing this specific product as a treatment for osteoporosis or any other individual condition. Administration and monitoring should always be guided by a qualified healthcare professional.

Global Presence :

Dolphin Pharmaceutical is an India-based manufacturer and exporter of finished pharmaceutical formulations and medical supplies. Our portfolio includes oncology, anti-HIV, diabetic, antihypertensive, hormonal medicines, ophthalmic eye drops, along with fibrin sealant kits, blood collection bags, hospital consumables and all surgical products.

We provide fast delivery within 10–12 days to over 25 countries as following:

• Caribbean: Antigua and Barbuda, The Bahamas, Barbados, Dominica, Dominican Republic, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago

• Africa: Nigeria, Kenya, Tunisia, Algeria, Ghana, Senegal, Somalia, Morocco.

• Asia: Indonesia, Vietnam, Thailand, Malaysia, Cambodia , Timor-Leste, the Philippines, Singapore.

All products are manufactured in compliance with GMP standards and WHO guidelines, ensuring quality and regulatory adherence. We supply reliable and cost-effective healthcare products to international markets, supporting bulk and customized requirements.